Definium Therapeutics, Inc. (DFTX) income statement
DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/30
$29.38−0.78 (-2.59%)
Close on Nov 17, 2026Market cap $3.95BP/E –Yield –
Definium Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -64.1%
Financial strength
- Current ratio
- 6.95
- Debt to equity
- 0.04
- Debt to assets
- 3.3%
- Cash to current liabilities
- 416.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.30
- Dividend yield
- –
See a number that looks wrong?